Voyager Therapeutics Investor Relations Material

Voyager Therapeutics Inc. is a biotechnology company focused on developing gene therapies for the treatment of severe neurological diseases. The company leverages its proprietary platform to create therapies designed to deliver genetic material directly to targeted cells in the brain and other parts of the nervous system. Voyager's research and development efforts focus on treating conditions such as Parkinson’s disease, Huntington’s disease, and other central nervous system disorders. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.